MoneyWorks4Me

Marksans Pharma’s arm gets Marketing Authorisation for Levetiracetam Relonchem Oral Solution

28 May 2024 Evaluate

Marksans Pharma’s wholly owned subsidiary -- Relonchem has received Marketing Authorization for the product Levetiracetam Relonchem 100 mg/mL Oral Solution from UK Medicines and Healthcare products Regulatory Agency (MHRA). The product will be manufactured at the Group’s UK manufacturing facility. 

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.


Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..